Center For Sight Clinical Studies Page
At Center For Sight in Florida, we are dedicated to pushing the boundaries of eye care through our active participation in clinical studies. Our team of experienced ophthalmologists and researchers work tirelessly to evaluate new treatments and technologies aimed at improving vision and treating various eye conditions. By staying at the forefront of clinical research, we ensure that our patients have access to the latest advancements in eye care. Through our commitment to innovation and excellence, we strive to provide the highest quality of vision care possible. Visit one of our convenient locations across Florida to experience our commitment to advancing eye care through clinical studies.
Ongoing Clinical Trials
Glaucoma
A Phase 3, Randomized, Multi-Regional, Double-Masked, Parallel-Group Trial Evaluating the Safety and Efficacy of NCX 470 0.1% vs. Latanoprost 0.005% in Subjects with Open-Angle Glaucoma or Ocular Hypertension (Denali)
Do you have glaucoma or high eye pressure?
If so, you may qualify for a new investigational eye drop research study!
If you have previously been diagnosed with glaucoma or increased eye pressure and are 18 to 84 years of age, we invite you to participate.
The study involves ~8 office visits over the course of ~ 6 months.
You may be compensated for your time and travel.
Speak with your doctor for more information and to find out if you qualify.
Study location: Center For Sight – Venice. Research@centerforsight.net / 941.480.2158
Status: Active, enrolling
A Prospective, Multicenter Clinical Study to Evaluate the Safety and Effectiveness of Ab Externo Implantation of Glaucoma Gel Stent.
Status: Active, enrolling
Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intraocular Implant) in Conjunction with the Placement of iStent Infinite vs. iStent Infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension.
HAVE YOU BEEN DIAGNOSED WITH GLAUCOMA?
We are currently conducting a study for people who have been diagnosed with glaucoma or high eye pressure
You may be a possible candidate for this study if you meet the following criteria:
- Male or female, 18 years of age or older
- Are on 0 to 2 ocular hypotensive medications
- No prior incisional glaucoma surgery
The objective of this study is to evaluate the safety and IOP-lowering efficacy of administering an iDose TR (travoprost intraocular implant) in conjunction with the placement of iStent infinite trabecular bypass system compared with placement of iStent infinite trabecular bypass system alone, in subjects with glaucoma or high eye pressure
The expected study duration is approximately 12 months
If you would like more information regarding this study, please contact our research department: Research@centerforsight.net / 941.480.2158
Status: Active, enrolling
Prospective, Randomized Phase III Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
Status: Active, enrollment closed
Cataract Surgery and Intraocular Lenses
Evaluation of the Symfony with Optiblue Intraocular Lens Compared to The Vivity IOL Under Mesopic Conditions.
Presbyopia correcting intraocular lenses (IOLs) are lenses designed to reduce the dependence on glasses after routine cataract surgery. If you have healthy eyes and have been diagnosed with cataracts in both eyes, or, if you are experiencing the symptoms of cataracts including cloudy vision and difficulty driving at night, you may qualify for this study. The study evaluates two already FDA-approved IOLs that could reduce your dependance on glasses.
Compensation is available for qualifying patients. Enrollment is limited. Medicare & most insurance accepted.
Status: Active, enrolling
Clinical Outcomes of Patients Bilaterally Implanted with the Commercially Available RxSight Light Adjustable Lens (LAL)
Status: Active, enrolling per invitation only
User Acceptability Evaluation of Pesudophakic Patients Previously Implanted with the TECNIS Odyssey IOL.
Status: Active, enrollment closed.
Hear From Our Patients
“I nervously but excitedly accepted an offer to be part of a tear troughs clinical study at Center for Sight supervised by Dr. John Fezza. My tear troughs were very deep and I wanted my eyes to look refreshed, which was achieved. He and his team of highly skilled technicians made the experience not only helpful for my tear troughs to be minimized but also made me actually look forward to my visits. Gina Thomas and Deb, whom I saw every time, made the visits fun and enjoyable. I would recommend anyone who is inclined to entertain the idea of a clinical study with this facility and their professional team, to definitely do so, as I have no regrets and would consider another study with them in the future. Blessed and grateful”
“As a retired nurse I did not have any qualms about participating in Dr Kim’s Glaucoma Study. In fact, I was thrilled to be asked to participate. I have always been a visual learner and recognize that my continued eyesight is a valuable asset for me. I love to watch the birds and am an orchid gardener so being able to contribute to advancements in the treatment of glaucoma and my sight was important to my lifestyle. Dr Kim and his research assistants were pleasant and made being a research subject educational and fun. Thanks to their expertise I am seeing better today!”
“I was in 2 study’s with the Research Department for a total of 6 years. They were very professional, thorough, and also down to earth. I looked forward to going to the appointments as if I was seeing old friends. They answered all the questions I had and offered more answers than I had even thought of. I would not hesitate about doing another research if it was offered to me. Great professional people.”
Past Clinical Trials
Cataract Surgery and Intraocular Lenses
Evaluation of Real-World Data on the Performance of the TECNIS Odyssey IOL
Status: Completed
Vision Performance Evaluation of TECNIS EYHANCE™ With TECNIS SIMPLICITY™ Compared to TECNIS® 1-piece Intraocular Lenses
Status: Completed
Evaluating the New Synergy IOL – First 7 Months Data From Two US Centers
Status: Completed
Status: Completed
Evaluating a novel strategy: The Synergy IOL mixed & matched with the Symfony w/Intelilight
Status: Completed
Post Approval Study of the Tecnis Symfony® Toric Lenses
Status: Completed
Glaucoma
A phase IV, prospective, 18-month study to assess the effectiveness and safety of
bimatoprost intracameral implant (DURYSTATM) in US clinical practice
Status: Completed
A Multi-Center, Open Label Rocklatan (Netarsudil/Latanoprost Ophthalmic solution) 0.02%/0.005% evaluation of IOP Lowering Efficacy and Safety as Replacement of Current Medical Therapy Regimen for the Reduction of Elevated Intraocular Pressure in Patients with Glaucoma or Ocular Hypertension
Status: Completed
The Hydrus Microstent for Refractory Open-Angle Glaucoma: A Prospective, Multicenter Clinical Trial (Hydrus VII Study)
Status: Completed
Randomized, Multicenter, Observer-Masked Study to Compare Safety/Efficacy of Nebivolol Suspension 0.5% or 1.0%, or Timolol Suspension 0.5% to Timolol Solution 0.5% in Participants with Primary Open Angle Glaucoma or Ocular Hypertension
Status: Completed
Prospective, Non-Randomized, Open-Label, Multi-Center, Single Arm Study of Exchange of Travoprost Intraocular Implant
Status: Completed
iStent Inject Trabecular Micro-Bypass System Continuation Post-Approval Study
Status: Completed
Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients with Open-Angle Glaucoma or Ocular Hypertension
Status: Completed
Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients with Glaucoma or Ocular Hypertension in a Real-world Setting
Status: Completed
Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients with Glaucoma and Ocular Hypertension
Status: Completed
A Randomized, Double-Masked, Active-Controlled, Parallel Group, Multi-Center Bioequivalence Study of The Generic Brinzolamide 1% Ophthalmic Suspension Compared to Reference Listed Drug Azopt® (Brinzolamide) Ophthalmic Suspension 1% In Subjects With Primary Open Angle Glaucoma Or Ocular Hypertension
Status: Completed
Oculoplastic
Teo-RHA-1902 A Randomized, Blinded Evaluator, No-Treatment Control, Multicenter, Prospective Clinical Study of RHA® 1 For the Treatment Of Moderate To Severe Tissue Volume Deficiencies In The Infraorbital Regions
Status: Completed
Efficacy and Safety Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines
Status: Completed
A Phase 2a, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Efficacy, Safety, and Duration of Benefit of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines
Status: Completed
A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLBELLA® XC Injectable Gel for Correction of Infraorbital Hollowing.
Status: Completed
A Research Study to See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects with Dry Eye Disease
Status: Completed
Presbyopia
A Multi-Center, Double-Masked Phase 3 Evaluation of the Long-Term Safety of LNZ101
in Presbyopic Subjects.
Status: Completed
Investigation of the Presbia Flexivue Microlens™ Prospective, Non-randomized, Unmasked, Multicenter Clinical Investigation of the Presbia Flexivue Microlens™ for the Improvement of Near Vision in Emmetropic Presbyopes.
Status: Completed
Other
Optos P200TE Agreement and Precision Study
Status: Completed
The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora.
Status: Completed
Retina
A Two-Year, Randomized, Double-Masked, Multicenter, Three-Arm Study Comparing the Efficacy and Safety of RTH258 Versus Aflibercept in Subjects With Neovascular Age-Related Macular Degeneration
Status: Completed
Safety and Efficacy of Abicipar Pegol (AGN‐150998) in Patients with Neovascular Age‐Related Macular Degeneration
Status: Completed
Treatment for Central-Involved Diabetic Macular Edema in Eyes With Very Good Visual Acuity
Status: Completed
Ocriplasmin Research to Better Inform Treatment (ORBIT)
Status: Completed
A Multicenter, Prospective Epidemiologic Study of The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Completed
To find out more about clinical study opportunities with Center For Sight please fill out the form below or contact us by phone or email.
Phone: (843) 380-2499
Email: research@centerforsight.net
Clinical Studies Interest Form
-
Naples
- 700 Neapolitan Way
- Naples, FL 34103
-
P: 239-544-3272
-
Brantley Road
- 1537 Brantley Rd
- Fort Myers, FL 33907
-
P: 239-766-7104
-
San Carlos Boulevard
- 15661 San Carlos Blvd Unit #4
- Fort Myers, FL 33908
-
P: 239-766-7136
-
Metropolis Ave
- 14290 Metropolis Ave, Ste #2
- Fort Myers, FL 33912
-
P: 239-766-7108
-
Port Charlotte
- 970 Kings Highway, suite 2
- Port Charlotte, FL 33980
-
P: 941-499-7863
-
Southwest Florida Eye Care – Naples
- 11176 Tamiami Trail N
- Naples, FL 34110
-
P: 239-594-0124
-
Southwest Florida Eye Care – Fort Myers
- 6850 International Center Blvd
- Fort Myers, FL 33912
-
P: 239-768-0006
-
Southwest Florida Eye Care – Cape Coral
- 2221 Santa Barbara Blvd. #107
- Cape Coral, FL 33991
-
P: 239-574-5406
- Follow Us
-
-
